Lista de obras -

A new oncoprotein catabolism pathway ⬇️

artículo científico publicado el 30 de septiembre de 2010

ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation

artículo científico publicado en 2014

Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway

artículo científico publicado en 2008

Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.

artículo científico publicado en 2010

CK2 and PML: regulating the regulator

artículo científico publicado en 2006

CLIPR-59 is a lipid raft-associated protein containing a cytoskeleton-associated protein glycine-rich domain (CAP-Gly) that perturbs microtubule dynamics

artículo científico publicado en 2004

Comment on "SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML".

artículo científico publicado en 2016

Detection of Protein SUMOylation In Situ by Proximity Ligation Assays

artículo científico publicado en 2016

Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation

scientific journal article

How acute promyelocytic leukaemia revived arsenic

artículo científico publicado en 2002

In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia

artículo científico publicado en 2002

Interferon controls SUMO availability via the Lin28 and let-7 axis to impede virus replication

artículo científico publicado en 2014

JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML

artículo científico publicado en 2021

Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia

artículo científico publicado en 2005

Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins

artículo científico publicado en 2014

PML is a ROS sensor activating p53 upon oxidative stress.

artículo científico publicado en 2017

PML nuclear bodies

artículo científico publicado en 2010

PML nuclear bodies and apoptosis

artículo científico publicado en 2004

PML nuclear bodies, membrane-less domains acting as ROS sensors?

artículo científico publicado en 2017

PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation

artículo científico publicado en 2014

PML nuclear bodies: from architecture to function

artículo científico publicado en 2018

PML nuclear bodies: regulation, function and therapeutic perspectives

artículo científico publicado en 2014

PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers

artículo científico publicado en 2018

PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3.

artículo científico publicado en 2010

Promyelocytic Leukemia Protein (PML) Controls Listeria monocytogenes Infection

scientific article published on 10 January 2017

Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism

artículo científico publicado en 2016

Publisher Correction: RING tetramerization is required for nuclear body biogenesis and PML sumoylation.

artículo científico publicado en 2018

RING tetramerization is required for nuclear body biogenesis and PML sumoylation.

artículo científico publicado en 2018

Retinoic acid plus arsenic trioxide, the ultimate panacea for acute promyelocytic leukemia?

artículo científico publicado en 2013

Stability of HTLV-2 antisense protein is controlled by PML nuclear bodies in a SUMO-dependent manner.

artículo científico publicado en 2018

Tax as a therapeutic target in ATL

Tax as a therapeutic target in ATL.

artículo científico publicado en 2015

Tax as a therapeutic target in ATL.

artículo científico publicado en 2015

The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies

artículo científico publicado en 2012

Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure

artículo científico publicado en 2009

["Pupils researchers", when the science opens its doors to the young people]

artículo científico publicado en 2009

[Forward - representation in life sciences: how technical evolution influenced our vision of life, from organism to single cell and molecule]

artículo científico publicado en 2010

Lista de obras de

A new oncoprotein catabolism pathway ⬇️

ATL response to arsenic/interferon therapy is triggered by SUMO/PML/RNF4-dependent Tax degradation

Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway

Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.

CK2 and PML: regulating the regulator

CLIPR-59 is a lipid raft-associated protein containing a cytoskeleton-associated protein glycine-rich domain (CAP-Gly) that perturbs microtubule dynamics

Comment on "SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML".

Detection of Protein SUMOylation In Situ by Proximity Ligation Assays

Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation

How acute promyelocytic leukaemia revived arsenic

In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia

Interferon controls SUMO availability via the Lin28 and let-7 axis to impede virus replication

JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML

Opinion: how patients have benefited from mouse models of acute promyelocytic leukaemia

Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins

PML is a ROS sensor activating p53 upon oxidative stress.

PML nuclear bodies

PML nuclear bodies and apoptosis

PML nuclear bodies, membrane-less domains acting as ROS sensors?

PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation

PML nuclear bodies: from architecture to function

PML nuclear bodies: regulation, function and therapeutic perspectives

PML-Regulated Mitochondrial Metabolism Enhances Chemosensitivity in Human Ovarian Cancers

PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3.

Promyelocytic Leukemia Protein (PML) Controls Listeria monocytogenes Infection

Promyelocytic Leukemia Protein, a Protein at the Crossroad of Oxidative Stress and Metabolism

Publisher Correction: RING tetramerization is required for nuclear body biogenesis and PML sumoylation.

RING tetramerization is required for nuclear body biogenesis and PML sumoylation.

Retinoic acid plus arsenic trioxide, the ultimate panacea for acute promyelocytic leukemia?

Stability of HTLV-2 antisense protein is controlled by PML nuclear bodies in a SUMO-dependent manner.

Tax as a therapeutic target in ATL

Tax as a therapeutic target in ATL.

Tax as a therapeutic target in ATL.

The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies

Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure

["Pupils researchers", when the science opens its doors to the young people]

[Forward - representation in life sciences: how technical evolution influenced our vision of life, from organism to single cell and molecule]